Pharmaresources: Announcement of Notice about Shareholders Holding More Than 5% of Shares Reducing to Less Than 5% and Changes in Equity
Pharmaresources: Simplified Equity Change Report
Pharmaresources: Announcement on the passive reaching of 5% shareholder holdings ratio and equity changes.
Pharmaresources: Simplified Equity Change Report
Pharmaresources: Announcement on adjusting the upper limit of share repurchase price after implementation of annual equity distribution in 2023.
Pharmaresources: Announcement of Annual Equity Distribution Implementation in 2023
Pharmaresources: Announcement on the progress of repurchasing the company's shares to reach 1% of the proportion.
Pharmaresources: Announcement on the lifting of the shareholder's equity pledge.
Pharmaresources: Announcement regarding the progress of repurchasing company shares.
Pharmaresources: Simplified Statement of Changes in Equity
Pharmaresources: An indicative announcement on shareholders' holdings of 5% or more reducing their holdings to less than 5% and changes in equity
Pharmaresources: Announcement on the progress of the repurchase of company shares
Pharmaresources: Announcement on shareholders holding 5% or more of the company's shares to reduce their holdings by 1% and the completion of the plan to reduce their holdings
Pharmaresources: Pre-disclosure announcement on plans to reduce shareholders' holdings of 5% or more
Hongbo Pharmaceutical: Announcement on the company's 2023 profit distribution plan
Hongbo Pharmaceutical: Progress Announcement on the Repurchase of the Company\'s Shares
Hongbo Pharmaceutical: Progress Announcement on the Repurchase of the Company's Shares
Hongbo Pharmaceutical: Pre-disclosure Notice on Shareholders' Shareholdings Reduction Plan for Shareholders Holding 5% or More of Their Shares
Hongbo Pharmaceutical: Announcement on the initial repurchase of the company's shares
Hongbo Pharmaceutical: Repurchase Report
No Data